Prescription drug · ANDA
Octreotide Acetate NDC 68083-516
Octreotide acetate 1000 ug/mL · Injection, Solution · Intravenous, Subcutaneous · Gland Pharma Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68083-516-01 | 68083051601 | 1 VIAL in 1 CARTON (68083-516-01) / 5 mL in 1 VIALMarketed from Jun 13, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Octreotide Acetate
- Generic name (nonproprietary)
- octreotide acetate
- Active ingredients
- Octreotide acetate — 1000 ug/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- Gland Pharma LimitedNDC labeler code 68083
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216807
- Marketing start
- Listing expires
- Other FDA classes
- Somatostatin Receptor Agonists (Mechanism)
- Identifiers
- Product ID 68083-516_5869eaa3-e390-4dff-97df-1adf431ef64fSPL ID 5869eaa3-e390-4dff-97df-1adf431ef64fSPL set ID 2344ae7a-c2f0-433b-9133-1dcb16bb18a0RxCUI 312071, 314152UNII 75R0U2568IUPC 0368083515010, 0368083516017
- Pharmacologic class
- Somatostatin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N468083051601followed by a unit qualifier and the quantityPackage 68083-0516-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Octreotide acetate injection is a somatostatin analogue indicated: Acromegaly : To reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1; somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses. ( 1.1 ) Carcinoid Tumors : For the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease. ( 1.2 ) Vasoactive Intestinal Peptide Tumors (VIPomas) : For the treatment of profuse watery diarrhea associated with VIP-secreting t…
Excerpt only. Read the full label for complete information.
About NDC 68083-516
- What is NDC 68083-516?
- 68083-516 is the product NDC for Octreotide Acetate, Octreotide acetate 1000 ug/mL injection, solution, listed with the FDA by Gland Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Octreotide Acetate.
- What is the active ingredient?
- Octreotide acetate.
- Who is the labeler?
- Gland Pharma Limited, NDC labeler code 68083. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Octreotide Acetate?
- 28 other product NDCs are listed under this name. See all Octreotide Acetate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Octreotide Acetate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Octreotide Acetate | — | Kit | Mylan Institutional LLC | 67457-756 | 67457-0756-10 |
| Octreotide Acetate | — | Kit | Mylan Institutional LLC | 67457-759 | 67457-0759-20 |
| Octreotide Acetate | — | Kit | Mylan Institutional LLC | 67457-762 | 67457-0762-30 |
| Octreotide Acetate | — | KitIntramuscular | Teva Pharmaceuticals, Inc. | 0480-9257 | 00480-9257-08 |
| Octreotide Acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals, Inc. | 71288-566 | 71288-0566-02 |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals, Inc. | 71288-567 | 71288-0567-02 |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Meitheal Pharmaceuticals, Inc. | 71288-568 | 71288-0568-02 |
| Octreotide Acetate | — | KitIntramuscular | Teva Pharmaceuticals, Inc. | 0480-9259 | 00480-9259-08 |
| Octreotide Acetate | — | KitIntramuscular | Teva Pharmaceuticals, Inc. | 0480-9262 | 00480-9262-08 |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 52958-046 | 52958-0046-10 |
Other NDCs under ANDA 216807
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Octreotide Acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Gland Pharma Limited | 68083-515 |